Pharmadax (4191)

Currency in TWD
8.10
+0.10(+1.25%)
Closed·
Showing Pharmadax historical data. For real-time data please try another search
Day's Range
6.808.31
52 wk Range
6.808.31
Key Statistics
Bid/Ask
43.70 / 44.39
Prev. Close
8
Open
7.66
Day's Range
6.8-8.31
52 wk Range
6.8-8.31
Volume
2.3M
Average Volume (3m)
2.07M
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Pharmadax Company Profile

Pharmadax Inc. engages in the pharmaceutical research and development business in Taiwan, the Unites States, and China. It primarily focuses on the development of oral solid controlled-release and oral pellet controlled-release systems. The company offers Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets, as well as contract development and/or contract manufacturing services for solid orals. It provides its products for a range of therapeutic areas, including schizophrenia, hypertension, diabetes, cold, Parkinson’s disease, ADHD, chronic hepatitis, overactive bladder, and muscle relaxant. The company was founded in 2008 and is headquartered in New Taipei City, Taiwan.

0
Market
Taiwan

Earnings

Latest Release
Aug 14, 2024
EPS / Forecast
-0.05 / --
Revenue / Forecast
306.38M / --
EPS Revisions
Last 90 days

4191 Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.